- Home
- / Endo International
Endo International
Revenue
$2 B
FY, 2023
Endo International Summary
Company Summary
- Overview
- Endo International is a pharmaceutical company. Its therapeutic areas include allergy immunotherapy, dermatology, infectious disease, insomnia, urology, etc.
- Type
- Private
- Status
- Closed
- Founded
- 1997
- HQ
- Dublin 4, IE | view all locations
- Cybersecurity rating
- ESG rating
- Sectors
Table of Contents
LocationsView all
20 locations detected
Dublin 4, D HQ
Ireland
2nd Floor, Minerva House, Simmonscourt Rd, Ballsbridge
Charlotte, NC
United States
3241 Woodpark Blvd
Charlotte, NC
United States
3700 Woodpark Blvd
Chestnut Ridge, NY
United States
1 Ram Ridge Rd
Chestnut Ridge, NY
United States
6 Ram Ridge Rd
Cranbury Township, NJ
United States
7 Clarke Dr, Cranbury
Endo International Financials
Summary Financials
- Revenue (FY, 2023)
- $2.0B
- Net income (FY, 2023)
- ($2.4B)
- Cash (FY, 2023)
- $777.9M
- EBIT (FY, 2023)
- ($2.4B)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026